Insulin resistance syndrome in children

Leslie K Scott1

  • 1University of Kentucky, College of Nursing, Lexington, KY, USA.

Pediatric Nursing
|May 25, 2006
PubMed

Insights

Insulin resistance, a metabolic issue affecting glucose metabolism, is increasingly seen in children and adolescents. Early detection in youth is crucial for preventing serious health conditions like obesity and type 2 diabetes.

Area of Science:

  • Metabolic health
  • Pediatric endocrinology
  • Public health

Background:

  • Insulin resistance is a metabolic dysfunction impacting glucose metabolism.
  • It is linked to obesity, hyperlipidemia, hypertension, cardiovascular disease, and type 2 diabetes, collectively known as insulin resistance syndrome.
  • While previously considered an adult condition, its components are now identified in children and adolescents.

Purpose of the Study:

  • To highlight the importance of identifying children at risk for insulin resistance.
  • To emphasize the need for early prevention and intervention strategies.
  • To underscore the role of primary care providers in recognizing and managing pediatric insulin resistance.

Main Methods:

  • This study is a review of current research on pediatric insulin resistance.
  • It synthesizes findings on the prevalence and components of insulin resistance syndrome in youth.
  • It discusses the implications for early detection and primary care.

Main Results:

  • Components of insulin resistance syndrome are present in children and adolescents.
  • Early identification of at-risk children is feasible and important.
  • Primary care settings are key for early recognition and treatment.

Conclusions:

  • Insulin resistance is a growing concern in pediatric populations.
  • Early intervention in children can prevent severe health consequences.
  • Primary care providers are essential for managing pediatric insulin resistance.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...